Quadrant Biosciences Inc — Form D/A

Quadrant Biosciences Inc of SYRACUSE, NY, a company, filed a Form D amendment with the SEC on 2016-04-14. The offering totals $5.0M, of which $3.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
David MacLeanDirectorSyracuse, NY
Peter CohenDirectorMiami, FL
Erica AshExecutive OfficerSyracuse, NY
James CrokeDirectorSyracuse, NY
James CrokeExecutive OfficerSyracuse, NY
Andrew RockDirectorBelleair Bluffs, FL
Richard BongoDirectorSyracuse, NY
Richard BongoExecutive OfficerSyracuse, NY
Nicholas GianaddaExecutive OfficerSyracuse, NY
Ira FedderDirectorSyracuse, NY
Mary Ann TyszkoDirectorSyracuse, NY
Bryan GreeneExecutive OfficerSyracuse, NY
Richard UhligDirectorSyracuse, NY
Richard UhligExecutive OfficerSyracuse, NY
Patrick BaileyExecutive OfficerSharpsburg, PA
Wade WestDirectorSyracuse, NY
Wade WestExecutive OfficerSyracuse, NY
Chris HoracekExecutive OfficerSyracuse, NY
Scott GiambalvoExecutive OfficerSYRACUSE, NY
Alexander RajanExecutive OfficerSyracuse, NY
Kayla WagnerExecutive OfficerSyracuse, NY
Andrew BrindleExecutive OfficerSyracuse, NY
Randy CarpenterExecutive OfficerSyracuse, NY
Benjamin PerryExecutive OfficerKaty, TX
Jeremy WilliamsExecutive OfficerSyracuse, NY

Other filings by this issuer (7)

FiledFormOfferingSold
2023-11-02D$25.4M
2023-08-08D$35.0M$3.5M
2020-01-23D$5.0M$2.3M
2019-06-27D$5.0M$450K
2016-12-13D$2.5M$2.1M
2016-04-13D/A$5.0M$3.6M
2015-08-19D$5.0M$435K

More